• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Genetic Testing in Clinical Settings.临床环境中的基因检测。
Am J Kidney Dis. 2018 Oct;72(4):569-581. doi: 10.1053/j.ajkd.2018.02.351. Epub 2018 Apr 11.
2
The role of pharmacogenomics in adverse drug reactions.药物基因组学在药物不良反应中的作用。
Expert Rev Clin Pharmacol. 2019 May;12(5):407-442. doi: 10.1080/17512433.2019.1597706. Epub 2019 Apr 24.
3
Facilitating clinical implementation of pharmacogenomics.促进药物基因组学的临床应用。
JAMA. 2011 Jul 20;306(3):304-5. doi: 10.1001/jama.2011.1010.
4
How Should Primary Care Physicians Respond to Direct-to-Consumer Genetic Test Results?基层医疗医生应如何应对面向消费者的基因检测结果?
AMA J Ethics. 2018 Sep 1;20(9):E812-818. doi: 10.1001/amajethics.2018.812.
5
New approaches to molecular diagnosis.分子诊断新方法。
JAMA. 2013 Apr 10;309(14):1511-21. doi: 10.1001/jama.2013.3239.
6
Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals: A Randomized Clinical Trial.检测和披露与肾功能衰竭相关的特定种族遗传风险对患者和医疗保健专业人员的影响:一项随机临床试验。
JAMA Netw Open. 2022 Mar 1;5(3):e221048. doi: 10.1001/jamanetworkopen.2022.1048.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Pharmacogenetics approach to therapeutics.治疗学的药物遗传学方法。
Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):525-32. doi: 10.1111/j.1440-1681.2006.04402.x.
9
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.一个 12 基因药物遗传学检测面板以预防药物不良反应:一项开放标签、多中心、对照、集群随机交叉实施研究。
Lancet. 2023 Feb 4;401(10374):347-356. doi: 10.1016/S0140-6736(22)01841-4.
10
Genetic studies in chronic kidney disease: interpretation and clinical applicability.慢性肾脏病的遗传学研究:解读与临床适用性
J Nephrol. 2012 Nov-Dec;25(6):851-64. doi: 10.5301/jn.5000216.

引用本文的文献

1
The current stage of Italy in the implementation of genomics into the National Healthcare System: an application of the B1MG maturity level model.意大利在将基因组学应用于国家医疗保健系统方面的当前阶段:B1MG成熟度水平模型的应用
Front Public Health. 2025 Apr 16;13:1425990. doi: 10.3389/fpubh.2025.1425990. eCollection 2025.
2
Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome-An Update.代谢综合征中与胰岛素抵抗相关的交互基因位点的鉴定——最新进展
Medicina (Kaunas). 2025 Jan 7;61(1):83. doi: 10.3390/medicina61010083.
3
The Polygenic Nature of Multiple Sclerosis: Genetic Variants, Immunological Modulation, and Environmental Connections.多发性硬化症的多基因性质:基因变异、免疫调节及与环境的关联
Endocr Metab Immune Disord Drug Targets. 2024 Dec 31. doi: 10.2174/0118715303325979241206115417.
4
Pharmacogenomic profiling of the South Korean population: Insights and implications for personalized medicine.韩国人群的药物基因组学分析:对个性化医疗的见解与启示。
Front Pharmacol. 2024 Dec 3;15:1476765. doi: 10.3389/fphar.2024.1476765. eCollection 2024.
5
Normalising the Implementation of Pharmacogenomic (PGx) Testing in Adult Mental Health Settings: A Theory-Based Systematic Review.使成人心理健康环境中药基因组学(PGx)检测的实施标准化:基于理论的系统评价。
J Pers Med. 2024 Sep 27;14(10):1032. doi: 10.3390/jpm14101032.
6
Advancing Genetic Testing in Kidney Diseases: Report From a National Kidney Foundation Working Group.推进肾脏病基因检测:美国肾脏基金会工作组报告。
Am J Kidney Dis. 2024 Dec;84(6):751-766. doi: 10.1053/j.ajkd.2024.05.010. Epub 2024 Jul 19.
7
Identification of Novel and Recurrent Variants in , , and Genes in Families with Metabolic Disorders in Saudi Arabia.沙特阿拉伯代谢紊乱家族中、、和基因的新型及复发性变异的鉴定。
J Clin Med. 2024 Feb 20;13(5):1193. doi: 10.3390/jcm13051193.
8
Understanding Challenges of Genetic Testing on Neuromuscular Disorders from the Parental Lens.从父母的视角理解基因检测对神经肌肉疾病的挑战。
J Pers Med. 2023 Nov 27;13(12):1652. doi: 10.3390/jpm13121652.
9
Association of Genetic and Allelic Variants of Von Willebrand Factor (VWF), Glutathione S-Transferase and Tumor Necrosis Factor Alpha with Ischemic Stroke Susceptibility and Progression in the Saudi Population.沙特人群中血管性血友病因子(VWF)、谷胱甘肽S-转移酶和肿瘤坏死因子α的基因及等位基因变异与缺血性中风易感性及进展的关联
Life (Basel). 2023 May 17;13(5):1200. doi: 10.3390/life13051200.
10
Renal Genetics Clinic: 3-Year Experience in the Cleveland Clinic.肾脏遗传学诊所:克利夫兰诊所的3年经验
Kidney Med. 2022 Dec 13;5(2):100585. doi: 10.1016/j.xkme.2022.100585. eCollection 2023 Feb.

本文引用的文献

1
Clinical Genetic Testing for APOL1: Are we There Yet?APOL1 临床基因检测:我们准备好了吗?
Semin Nephrol. 2017 Nov;37(6):552-557. doi: 10.1016/j.semnephrol.2017.07.009.
2
Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.常染色体显性遗传多囊肾病和肝病的遗传复杂性。
J Am Soc Nephrol. 2018 Jan;29(1):13-23. doi: 10.1681/ASN.2017050483. Epub 2017 Oct 16.
3
Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe.通过面向消费者的基因检测公司23andMe进行药物遗传学检测。
BMC Med Genomics. 2017 Jun 19;10(1):47. doi: 10.1186/s12920-017-0283-0.
4
Direct-to-Consumer Medical Testing in the Era of Value-Based Care.基于价值医疗时代的直接面向消费者的医学检测
JAMA. 2017 Jun 27;317(24):2485-2486. doi: 10.1001/jama.2017.5929.
5
Finding the Rare Pathogenic Variants in a Human Genome.在人类基因组中寻找罕见的致病变异体。
JAMA. 2017 May 9;317(18):1904-1905. doi: 10.1001/jama.2017.0432.
6
HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects.北美HIV感染受试者中HLA - B*57:01等位基因的流行率以及等位基因检测对HLA - B*57:01阴性受试者中阿巴卡韦相关超敏反应发生率的影响。
BMC Infect Dis. 2017 Apr 11;17(1):256. doi: 10.1186/s12879-017-2331-y.
7
Focal Segmental Glomerulosclerosis.局灶节段性肾小球硬化症
Clin J Am Soc Nephrol. 2017 Mar 7;12(3):502-517. doi: 10.2215/CJN.05960616. Epub 2017 Feb 27.
8
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.临床药物基因组学实施联盟(CPIC)华法林给药的药物基因组学指导原则:2017年更新版
Clin Pharmacol Ther. 2017 Sep;102(3):397-404. doi: 10.1002/cpt.668. Epub 2017 Apr 4.
9
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.临床外显子组和基因组测序中次要发现报告的建议,2016年更新版(美国医学遗传学与基因组学学会次要发现v2.0):美国医学遗传学与基因组学学会政策声明
Genet Med. 2017 Feb;19(2):249-255. doi: 10.1038/gim.2016.190. Epub 2016 Nov 17.
10
Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.简短报告:在肾功能受损的HIV感染成人中换用与埃替拉韦、考比司他和恩曲他滨联合配方的替诺福韦艾拉酚胺:一项单臂、多中心、开放标签3期研究的96周结果
J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):180-184. doi: 10.1097/QAI.0000000000001186.

临床环境中的基因检测。

Genetic Testing in Clinical Settings.

机构信息

Department of Epidemiology, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC.

Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC.

出版信息

Am J Kidney Dis. 2018 Oct;72(4):569-581. doi: 10.1053/j.ajkd.2018.02.351. Epub 2018 Apr 11.

DOI:10.1053/j.ajkd.2018.02.351
PMID:29655499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6153053/
Abstract

Genetic testing is used for screening, diagnosis, and prognosis of diseases consistent with a genetic cause and to guide drug therapy to improve drug efficacy and avoid adverse effects (pharmacogenomics). This In Practice review aims to inform about DNA-related genetic test availability, interpretation, and recommended clinical actions based on results using evidence from clinical guidelines, when available. We discuss challenges that limit the widespread use of genetic information in the clinical care setting, including a small number of actionable genetic variants with strong evidence of clinical validity and utility, and the need for improving the health literacy of health care providers and the public, including for direct-to-consumer tests. Ethical, legal, and social issues and incidental findings also need to be addressed. Because our understanding of genetic factors associated with disease and drug response is rapidly increasing and new genetic tests are being developed that could be adopted by clinicians in the short term, we also provide extensive resources for information and education on genetic testing.

摘要

基因检测用于筛查、诊断和预测符合遗传原因的疾病,并指导药物治疗以提高药物疗效和避免不良反应(药物基因组学)。本实践综述旨在根据临床指南中的证据,就基于 DNA 的相关遗传检测的可用性、解释和推荐的临床操作提供信息,这些指南在可用时会被使用。我们讨论了限制遗传信息在临床护理环境中广泛应用的挑战,包括具有明确临床有效性和实用性的少数可操作遗传变异,以及需要提高医疗保健提供者和公众的健康素养,包括直接面向消费者的检测。还需要解决伦理、法律和社会问题以及偶然发现。由于我们对与疾病和药物反应相关的遗传因素的理解正在迅速增加,并且正在开发新的遗传检测方法,这些方法可能会在短期内被临床医生采用,因此我们还提供了广泛的遗传检测信息和教育资源。